Danish start-up Fuse Vectors has received $5.2 million in preseed financing to further develop their gene therapy technology.

Some of the most forward-thinking business and social impact leaders in the world share seven lessons for what businesses ...

Advances Pacira's“5x30” path to becoming an innovative biopharmaceutical organization -- -- Adds novel, high-capacity, local-delivery pl ...

While air travel demand has recovered from the COVID-19 pandemic and then some, aircraft production and its supply chain ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its breakthrough approach, Fuse Vectors aims to be the universal solution for AAV ...